No retraction, correction or concern found when last checked on Oct 26, 2026.

Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom

Nicola J. Adderley, Anuradhaa Subramanian, Krishnarajah Nirantharakumar and 4 more

JAMA Neurology · 2019

doi:10.1001/jamaneurol.2019.1812

Abstract

Question. Is the risk of cardiovascular disease greater in women with idiopathic intracranial hypertension than in women of the same age and body mass index but without idiopathic intracranial hypertension?

Findings. In this population-based matched controlled cohort study of 2760 female patients with idiopathic intracranial hypertension and 27 125 control patients, women with this condition had twice the risk for cardiovascular disease compared with their counterparts with similar body mass index and age. Between 2005 and 2017, the incidence and prevalence of idiopathic intracranial hypertension have tripled.

Meaning. Idiopathic intracranial hypertension appeared to be a risk factor for cardiovascular disease in women; changing patient management to address the risk factors for cardiovascular disease may reduce long-term morbidity.

Importance. Cardiovascular disease (CVD) risk has not been previously evaluated in a large matched cohort study in idiopathic intracranial hypertension (IIH).

Objectives. To estimate the risk of composite cardiovascular events, heart failure, ischemic heart disease, stroke/transient ischemic attack (TIA), type 2 diabetes, and hypertension in women with idiopathic intracranial hypertension and compare it with the risk in women, matched on body mass index (BMI) and age, without the condition; and to evaluate the prevalence and incidence of IIH.

Design, Setting, and Participants. This population-based matched controlled cohort study used 28 years of data, from January 1, 1990, to January 17, 2018, from The Health Improvement Network (THIN), an anonymized, nationally representative electronic medical records database in the United Kingdom. All female patients aged 16 years or older were eligible for inclusion. Female patients with IIH (n = 2760) were included and randomly matched with up to 10 control patients (n = 27 125) by BMI and age.

Main Outcomes and Measures. Adjusted hazard ratios (aHRs) of cardiovascular outcomes were calculated using Cox regression models. The primary outcome was a composite of any CVD (heart failure, ischemic heart disease, and stroke/TIA), and the secondary outcomes were each CVD outcome, type 2 diabetes, and hypertension.

Results. In total, 2760 women with IIH and 27 125 women without IIH were included. Age and BMI were similar between the 2 groups, with a median (interquartile range) age of 32.1 (25.6-42.0) years in the exposed group and 32.1 (25.7-42.1) years in the control group; in the exposed group 1728 women (62.6%) were obese, and in the control group 16514 women (60.9%) were obese. Higher absolute risks for all cardiovascular outcomes were observed in women with IIH compared with control patients. The aHRs were as follows: composite cardiovascular events, 2.10 (95% CI, 1.61-2.74; P <.001); heart failure, 1.97 (95% CI, 1.16-3.37; P =.01); ischemic heart disease, 1.94 (95% CI, 1.27-2.94; P =.002); stroke/TIA, 2.27 (95% CI, 1.61-3.21; P <.001); type 2 diabetes, 1.30 (95% CI, 1.07-1.57; P =.009); and hypertension, 1.55 (95% CI, 1.30-1.84; P <.001). The incidence of IIH in female patients more than tripled between 2005 and 2017, from 2.5 to 9.3 per 100 000 person-years. Similarly, IIH prevalence increased in the same period, from 26 to 79 per 100 000 women. Incidence increased markedly with BMI higher than 30.

Conclusions and Relevance. Idiopathic intracranial hypertension in women appeared to be associated with a 2-fold increase in CVD risk; change in patient care to modify risk factors for CVD may reduce long-term morbidity for women with IIH and warrants further evaluation.

References 51

1.
Markey KA, Mollan SP, Jensen RH, Sinclair AJ Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016;15(1):78-91
Not in our library10.1016/s1474-4422(15)00298-7
2.
Mulla Y, Markey KA, Woolley RL, Patel S, Mollan SP, Sinclair AJ Headache determines quality of life in idiopathic intracranial hypertension. J Headache Pain. 2015;16:521
Not in our library10.1186/s10194-015-0521-9
3.
The expanding burden of idiopathic intracranial hypertension · 2018
No notice
4.
Friedman DI, Liu GT, Digre KB Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159-1165
Not in our library10.1212/wnl.0b013e3182a55f17
5.
Idiopathic intracranial hypertension: consensus guidelines on management · 2018
No notice
6.
Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management · 2016
No notice
7.
Daniels AB, Liu GT, Volpe NJ, Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007;143(4):635-641
Not in our library10.1016/j.ajo.2006.12.040
8.
The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis · 2009
No notice
9.
Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G; Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects) Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014;383(9921):970-983
Not in our library10.1016/s0140-6736(13)61836-x
10.
Fontana L, Hu FB Optimal body weight for health and longevity: bridging basic, clinical, and population research. Aging Cell. 2014;13(3):391-400
Not in our library10.1111/acel.12207
11.
O’Reilly MW, Westgate CSJ, Hornby C, A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 2019;4(6):e125348
Not in our library10.1172/jci.insight.125348
12.
Ding EL, Song Y, Malik VS, Liu S Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295(11):1288-1299
Not in our library10.1001/jama.295.11.1288
13.
Dalmasso C, Maranon R, Patil C, Cardiometabolic effects of chronic hyperandrogenemia in a new model of postmenopausal polycystic ovary syndrome. Endocrinology. 2016;157(7):2920-2927
Not in our library10.1210/en.2015-1617
14.
Azziz R, Carmina E, Dewailly D,; Androgen Excess Society Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91(11):4237-4245
Not in our library10.1210/jc.2006-0178
15.
Morgan CL, Jenkins-Jones S, Currie CJ, Rees DA Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab. 2012;97(9):3251-3260
Not in our library10.1210/jc.2012-1690
16.
Mani H, Levy MJ, Davies MJ, Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study. Clin Endocrinol (Oxf). 2013;78(6):926-934
Not in our library10.1111/cen.12068
17.
Randeva HS, Tan BK, Weickert MO, Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev. 2012;33(5):812-841
Not in our library10.1210/er.2012-1003
18.
General Practitioners Committee NHS Employers and NHS England. 2016/17 General Medical Services (GMS) Contract Quality and Outcomes Framework (QOF) Guidance for GMS Contract 2016/17. https://www.http://nhsemployers.org/-/media/Employers/Documents/Primary-care-contracts/QOF/2016-17/2016-17-QOF-guidance-documents.pdf. Published April 2016. Accessed May 31, 2019.
Not in our library
19.
Doran T, Fullwood C, Gravelle H, Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med. 2006;355(4):375-384
Not in our library10.1056/nejmsa055505
20.
Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007;16(4):393-401
Not in our library10.1002/pds.1335
21.
Lévesque LE, Hanley JA, Kezouh A, Suissa S Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ. 2010;340:b5087
Not in our library10.1136/bmj.b5087
22.
NHS Digital Business Rules for Quality and Outcomes Framework (QOF) 2017/18 Secondary Prevention of Coronary Heart Disease (CHD). Leeds, England: NHS Digital; 2017.
Not in our library
23.
Adams J, Ryan V, White M How accurate are Townsend deprivation scores as predictors of self-reported health? a comparison with individual level data. J Public Health (Oxf). 2005;27(1):101-106
Not in our library10.1093/pubmed/fdh193
24.
Frič R, Pripp AH, Eide PK Cardiovascular risk factors in Chiari malformation and idiopathic intracranial hypertension. Brain Behav. 2017;7(5):e00677
Not in our library10.1002/brb3.677
25.
Best J, Silvestri G, Burton B, Foot B, Acheson J The incidence of blindness due to idiopathic intracranial hypertension in the UK. Open Ophthalmol J. 2013;7(7):26-29
Not in our library10.2174/1874364101307010026
26.
Bigal ME, Kurth T, Santanello N, Migraine and cardiovascular disease: a population-based study. Neurology. 2010;74(8):628-635
Not in our library10.1212/wnl.0b013e3181d0cc8b
27.
Yiangou A, Mitchell J, Markey KA, Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: minimal gain, is it worth the pain? Cephalalgia. 2019;39(2):245-253
Not in our library10.1177/0333102418782192
28.
Canoy D, Luben R, Welch A, Fat distribution, body mass index and blood pressure in 22,090 men and women in the Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk) study. J Hypertens. 2004;22(11):2067-2074
Not in our library10.1097/00004872-200411000-00007
29.
Yusuf S, Hawken S, Ounpuu S,; INTERHEART Study Investigators Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640-1649
Not in our library10.1016/s0140-6736(05)67663-5
30.
Grundy SM, Adams-Huet B, Vega GL Variable contributions of fat content and distribution to metabolic syndrome risk factors. Metab Syndr Relat Disord. 2008;6(4):281-288
Not in our library10.1089/met.2008.0026
31.
Hornby C, Botfield H, O’Reilly MW, Evaluating the fat distribution in idiopathic intracranial hypertension using dual-energy X-ray absorptiometry scanning. Neuroophthalmology. 2017;42(2):99-104
Not in our library10.1080/01658107.2017.1334218
32.
Sinclair AJ, Burdon MA, Nightingale PG, Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341:c2701
Not in our library10.1136/bmj.c2701
33.
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants · 2016
No notice
34.
Kilgore KP, Lee MS, Leavitt JA, Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity. Ophthalmology. 2017;124(5):697-700
Not in our library10.1016/j.ophtha.2017.01.006
35.
Curry WT Jr, Butler WE, Barker FG II Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery. 2005;57(1):97-108
Not in our library10.1227/01.neu.0000163094.23923.e5
36.
Marmot M Social determinants of health inequalities. Lancet. 2005;365(9464):1099-1104
Not in our library10.1016/s0140-6736(05)74234-3
37.
Wilkinson R, Marmot M, eds. Social Determinants of Health: The Solid Facts 2nd edition. Geneva, Switzerland: World Health Organization; 2003:31.
Not in our library
38.
Pickett KE, Pearl M Multilevel analyses of neighbourhood socioeconomic context and health outcomes: a critical review. J Epidemiol Community Health. 2001;55(2):111-122
Not in our library10.1136/jech.55.2.111
39.
Phillimore P, Beattie A, Townsend P Widening inequality of health in northern England, 1981-91. BMJ. 1994;308(6937):1125-1128
Not in our library10.1136/bmj.308.6937.1125
40.
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37-43
Not in our library10.1016/s0140-6736(12)60240-2
41.
Herman WH, Ye W, Griffin SJ, Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe). Diabetes Care. 2015;38(8):1449-1455
Not in our library10.2337/dc14-2459
42.
Feldman AL, Griffin SJ, Fhärm E, Screening for type 2 diabetes: do screen-detected cases fare better? Diabetologia. 2017;60(11):2200-2209
Not in our library10.1007/s00125-017-4402-4
43.
Ottridge R, Mollan SP, Botfield H, Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol. BMJ Open. 2017;7(9):e017426
Not in our library10.1136/bmjopen-2017-017426
44.
Hall GC Validation of death and suicide recording on the THIN UK primary care database. Pharmacoepidemiol Drug Saf. 2009;18(2):120-131
Not in our library10.1002/pds.1686
45.
Seminara NM, Abuabara K, Shin DB, Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol. 2011;164(3):602-609.
Not in our library10.1111/j.1365-2133.2010.10134.x
46.
Cooper AR, Page A, Fox KR, Misson J Physical activity patterns in normal, overweight and obese individuals using minute-by-minute accelerometry. Eur J Clin Nutr. 2000;54(12):887-894
Not in our library10.1038/sj.ejcn.1601116
47.
Chen Y, Mao Y Obesity and leisure time physical activity among Canadians. Prev Med. 2006;42(4):261-265
Not in our library10.1016/j.ypmed.2006.01.006
48.
Diaz KM, Shimbo D Physical activity and the prevention of hypertension. Curr Hypertens Rep. 2013;15(6):659-668
Not in our library10.1007/s11906-013-0386-8
49.
Heymsfield SB, Gonzalez MC, Lu J, Jia G, Zheng J Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia. Proc Nutr Soc. 2015;74(4):355-366
Not in our library10.1017/s0029665115000129
50.
Park J, Ishikawa-Takata K, Tanaka S, Relation of body composition to daily physical activity in free-living Japanese adult women. Br J Nutr. 2011;106(7):1117-1127
Not in our library10.1017/s0007114511001358
51.
Park J, Ishikawa-Takata K, Tanaka S, The relationship of body composition to daily physical activity in free-living Japanese adult men. Br J Nutr. 2014;111(1):182-188
Not in our library10.1017/s0007114513001918

Cited by papers we hold 2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.